Niu Shilian, Li Rao, Yuan Li, Huang Dan
Department of Endocrinology and Metabolism, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China.
J Diabetes Res. 2025 May 26;2025:9142949. doi: 10.1155/jdr/9142949. eCollection 2025.
Patients experiencing stigma are more prone to engage in unhealthy behaviors. The correlation between stigma and health-promoting behaviors in overweight/obese T2DM patients is unclear. Therefore, this study aimed to investigate the association between the two in this particular population. This cross-sectional study, conducted from July 2022 to July 2023 at the Department of Endocrinology and Metabolism of a tertiary general hospital in Chengdu, Sichuan Province, China, used convenience sampling to enroll overweight/obese T2DM patients. A structured questionnaire was used to obtain information on sociodemographic and clinical characteristics. Respondents were assessed for stigma and health-promoting behaviors using the SSCI and T2DHPS scales. Data were analyzed using SPSS version 27.0, with a significance level of < 0.05. The majority was males (64%). The average BMI of patients was 27.27 ± 3.11 (kg/m), and the average HbA1c was 8.36 ± 1.81 (mmol/mol). The overall stigma score of overweight/obese T2DM patients was 4.19 ± 8.69, and the overall health-promoting behaviors score was 87.75 ± 16.75. Pearson correlation analysis revealed a significant correlation between stigma and the overall score of health promotion behaviors ( = -0.144, < 0.05). The multiple linear regression analysis showed that the hypoglycemia incidence, patient origin, GLP-1RA use, and stress management explained 23.9% of the patients' feelings of stigma. This study found that there was a correlation between the level of stigma and health-promoting behaviors in overweight/obese patients with T2DM. Hypoglycemia, inpatient, GLP-1RA treatment, and stress management significantly predicted stigma among overweight/obese patients. These findings have implications for healthcare providers, as they can develop intervention strategies by assessing the levels of stigma and stress management in overweight/obese patients with T2DM, to help reduce stigma and promote healthy behaviors among these patients.
遭受污名化的患者更容易从事不健康行为。超重/肥胖的2型糖尿病患者中，污名与健康促进行为之间的相关性尚不清楚。因此，本研究旨在调查这一特定人群中两者之间的关联。本横断面研究于2022年7月至2023年7月在中国四川省成都市一家三级综合医院的内分泌代谢科进行，采用便利抽样法纳入超重/肥胖的2型糖尿病患者。使用结构化问卷获取社会人口学和临床特征信息。使用SSCI和T2DHPS量表对受访者的污名和健康促进行为进行评估。使用SPSS 27.0版进行数据分析，显著性水平<0.05。大多数为男性（64%）。患者的平均BMI为27.27±3.11（kg/m），平均糖化血红蛋白为8.36±1.81（mmol/mol）。超重/肥胖的2型糖尿病患者的总体污名评分为4.19±8.69，总体健康促进行为评分为87.75±16.75。Pearson相关分析显示，污名与健康促进行为的总体评分之间存在显著相关性（=-0.144，<0.05）。多元线性回归分析表明，低血糖发生率、患者来源、GLP-1RA使用情况和压力管理可解释患者23.9%的污名感受。本研究发现，超重/肥胖的2型糖尿病患者的污名水平与健康促进行为之间存在相关性。低血糖、住院患者、GLP-1RA治疗和压力管理显著预测超重/肥胖患者的污名。这些发现对医疗服务提供者具有启示意义，因为他们可以通过评估超重/肥胖的2型糖尿病患者的污名水平和压力管理情况来制定干预策略，以帮助减少这些患者的污名并促进其健康行为。
